While the Indian economy is slowly opening up, the citizens are still awry about venturing out and travelling for work owing to the COVID-19 pandemic. Additionally, healthcare providers are looking for more ways in which testing can be done on a mass scale.
In accordance to this, an Israeli start-up company, Vocalis Health is bringing a unique and proven technology which uses “voice” as a marker of early detection, for both symptomatic as well as asymptomatic patients. Vocalis Health has developed an artificial intelligence (AI)-based platform that analyses voice to assess the health status of a person. The technology facilitates healthcare providers to remotely interact with patients for screening and monitoring patients with a variety of voice-affecting diseases, including chronic respiratory, various cardiac conditions and neurological conditions including depression. Current measures of using temperature checks and oxygen levels for screening may not be adequate especially in case of asymptomatic patients. Since COVID19 affects the respiratory system, it directly affects the throat and can be very efficiently captured by “voice” as a biomarker.
This technology is being used at the few top hospitals in Israel, like Sheba Medical Centre which is one of the top 10 hospitals in the world and Rabin Medical Centre. Closer home, India and Israel are collaborating to develop rapid diagnostic solutions for the virus. Vocalis Health is one of the four diagnostic companies and a part of a high-level delegation that has flown in from Israel to detect the virus.
Additionally, the Brihan Mumbai Corporation (BMC) has signed a MOU with Vocalis Health for doing some sample testing of patients. Currently, a limited number of voice samples will be tested in Mumbai. Depending upon the scale on the audio tests, the severity of the disease will be determined. While all the testing using this AI platform is being done at a preliminary stage, hopefully the results will be encouraging and helpful in the early detection and containment of the virus.
For further queries, contact:
Ms.Yogita Kale, Trade Officer, Mumbai.